Actuate Therapeutics (ACTU) Cash from Operations (2023 - 2025)
Actuate Therapeutics (ACTU) posted quarterly Cash from Operations of 3736043.0 for Q4 2025, up 21.72% year-over-year from 3069478.65 in Q4 2024, and up 44.05% quarter-over-quarter from 6677709.0 in Q3 2025.
Actuate Therapeutics (ACTU) Cash from Operations (2023 - 2025) Analysis & Trends
Actuate Therapeutics (ACTU) has reported Cash from Operations for 3 consecutive years, with 3736043.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Cash from Operations rose 21.72% year-over-year to 3736043.0; the TTM figure through Dec 2025 stood at 19206253.0 (up 12.07% YoY), while the FY2025 annual figure was 19206253.0, up 12.07% from the prior year.
- Cash from Operations improved to 3736043.0 in Q4 2025 per ACTU's latest filing, from 6677709.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 2673638.0 in Q2 2024 and bottomed at 9149013.0 in Q3 2024.
- Historically, Cash from Operations has averaged 5219899.6 across 3 years, with a median of 5009998.5 in 2024.
- Annual changes were most pronounced in 2024 — Cash from Operations sank 62.27% — and 2025, when it climbed 27.01%.
- Actuate Therapeutics' Cash from Operations stood at 5511844.0 in 2023, then increased by 13.42% to 4772415.0 in 2024, then grew by 21.72% to 3736043.0 in 2025.
- Business Quant data shows ACTU's Cash from Operations at 3736043.0 in Q4 2025, 6677709.0 in Q3 2025, and 4173761.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -526.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 462.82 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 326.72 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.27 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -88.83 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 728.46 Mn |
| 10 | Actuate Therapeutics | 30.08 Mn | 30.08 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.74 Mn |
| Dec 31, 2025 | -3.74 Mn |
| Sep 30, 2025 | -6.68 Mn |
| Sep 30, 2025 | -6.68 Mn |
| Jun 30, 2025 | -4.17 Mn |
| Jun 30, 2025 | -4.17 Mn |
| Mar 31, 2025 | -4.62 Mn |
| Mar 31, 2025 | -4.62 Mn |
| Dec 31, 2024 | -4.77 Mn |
| Dec 31, 2024 | -4.77 Mn |
| Sep 30, 2024 | -9.15 Mn |
| Sep 30, 2024 | -9.15 Mn |
| Jun 30, 2024 | -2.67 Mn |
| Jun 30, 2024 | -2.67 Mn |
| Mar 31, 2024 | -5.25 Mn |
| Mar 31, 2024 | -5.25 Mn |
| Dec 31, 2023 | -5.51 Mn |
| Dec 31, 2023 | -5.51 Mn |
| Sep 30, 2023 | -5.64 Mn |
| Sep 30, 2023 | -5.64 Mn |